COVID-19 Impact on Asia-Pacific Hospitals: Edition 3 L.E.K. Consulting and GRG Health Survey Presentations June 25, 2020 Fabio La Mola Stephen Sunderland Rishabh Bhawsar Manan Sethi
Life Sciences & Pharma Published Articles After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid… June 17, 2020 After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth.
Life Sciences & Pharma Video / Webinar How Have Hospitals Across APAC Adapted to the Impact of COVID-19? April 8, 2021 L.E.K. Consulting’s survey of hospital executives at private and public hospitals in the Asia Pacific region reveals three key themes.
Life Sciences & Pharma Presentations European Disease Progression Monitor: Edition 7 May 26, 2020 The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies across the Life Sciences and…
Digital Healthcare Executive Insights Navigating the Digital Health Reimbursement Landscape in Asia-Pacific August 21, 2020 L.E.K. and APACMed explored the reimbursement and broader monetization of digital health across APAC, identifying best practices used by some digital…
Digital Healthcare Presentations 2020 Asia-Pacific (APAC) Digital Readiness for the Healthcare Sector May 5, 2020 L.E.K. Consulting and Galen Growth conducted a survey of ~90 industry leaders in Q4 2019 to assess the digital readiness of healthcare sectors and…
Life Sciences & Pharma Presentations European Disease Progression Monitor: Edition 6 May 11, 2020 The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies
